| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |